Abbott Laboratories (Germany) Today
| ABL Stock | EUR 115.20 1.00 0.86% |
PerformanceModest
| Odds Of DistressLow
|
Abbott Laboratories is trading at 115.20 as of the 21st of March 2025. This is a 0.86 percent down since the beginning of the trading day. The stock's lowest day price was 114.96. Abbott Laboratories has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is based in North Chicago, Illinois. ABBOTT LABS operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. The company has 1.74 B outstanding shares. More on Abbott Laboratories
Moving together with Abbott Stock
| 0.98 | ABL | Abbott Laboratories | PairCorr |
| 0.84 | 2M6 | Medtronic PLC | PairCorr |
| 0.72 | BSX | Boston Scientific | PairCorr |
| 0.66 | SHL | Siemens Healthineers | PairCorr |
Moving against Abbott Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Abbott Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Abbott Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Abbott Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Abbott Laboratories (ABL) is traded on Frankfurt Exchange in Germany and employs 115,000 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 167.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbott Laboratories's market, we take the total number of its shares issued and multiply it by Abbott Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Abbott Laboratories classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 1.74 B outstanding shares.
Abbott Laboratories has accumulated about 8.37 B in cash with 9.58 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.71.
Check Abbott Laboratories Probability Of Bankruptcy
Ownership AllocationAbbott Laboratories holds a total of 1.74 Billion outstanding shares. The majority of Abbott Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Abbott Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Abbott Laboratories. Please pay attention to any change in the institutional holdings of Abbott Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Abbott Ownership Details
Abbott Laboratories Risk Profiles
Although Abbott Laboratories' alpha and beta are two of the key measurements used to evaluate Abbott Laboratories' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.09 | |||
| Semi Deviation | 1.39 | |||
| Standard Deviation | 1.43 | |||
| Variance | 2.05 |
Abbott Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Abbott Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Abbott Laboratories Corporate Management
Elected by the shareholders, the Abbott Laboratories' board of directors comprises two types of representatives: Abbott Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abbott. The board's role is to monitor Abbott Laboratories' management team and ensure that shareholders' interests are well served. Abbott Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abbott Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Leinenweber | Licensing Relations | Profile | |
| Robert Ford | Pres Chairman | Profile | |
| James Young | VP Officer | Profile | |
| Elaine Leavenworth | VP Officer | Profile | |
| Mary Moreland | Ex HR | Profile | |
| Robert Funck | Exec CFO | Profile | |
| Daniel Salvadori | Ex Products | Profile |
Additional Information and Resources on Investing in Abbott Stock
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Abbott Stock please use our How to Invest in Abbott Laboratories guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.